Literature DB >> 1986676

Prognosis of idiopathic pulmonary fibrosis in patients with mucous hypersecretion.

N Hiwatari1, S Shimura, T Sasaki, T Aikawa, Y Ando, H Ishihara, K Sekizawa, H Sasaki, T Takishima.   

Abstract

In order to determine the prognosis of patients with chronic idiopathic pulmonary fibrosis (IPF), we evaluated clinical, laboratory, and bronchoalveolar lavage (BAL) data at the onset of IPF in 25 patients who survived beyond 1 yr (nine women and 16 men, 59 +/- 3 yr of age, mean +/- SE). When the patients were divided into two groups according to whether they had or did not have mucous hypersecretion, 11 patients with hypersecretion (Group A) had a poorer survival rate (6 yr) than did 14 patients without hypersecretion (Group B) (10 yr) (p less than 0.01). Further, there was a significant negative correlation between sputum volume and the duration of survival in 25 patients (r = -0.55, p less than 0.01). Before glucocorticoid treatment, we also found significantly larger numbers of neutrophils (17%) and eosinophils (5%) in differential cell counts of bronchoalveolar lavage fluid (BALF) in Group A than in Group B (neutrophils, 1%; eosinophils, 0.6%) (p less than 0.05 each). Chest radiographic findings and other laboratory data including pulmonary function tests did not correlate with the survival rate. These findings suggest that mucous hypersecretion as well as neutrophils and eosinophils in BALF are among the determinants of prognosis in patients with chronic IPF.

Entities:  

Mesh:

Year:  1991        PMID: 1986676     DOI: 10.1164/ajrccm/143.1.182

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

Review 1.  Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.

Authors:  Talmadge E King
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

2.  Gender-based differences in bleomycin-induced pulmonary fibrosis.

Authors:  Mehrnaz Gharaee-Kermani; Kazuo Hatano; Yasuhiro Nozaki; Sem H Phan
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

3.  Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis.

Authors:  Francois Huaux; M Gharaee-Kermani; Tianju Liu; Valérie Morel; Bridget McGarry; Matt Ullenbruch; Steven L Kunkel; Jun Wang; Zhou Xing; Sem H Phan
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 4.  The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Benjamin D Bringardner; Christopher P Baran; Timothy D Eubank; Clay B Marsh
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 5.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.

Authors:  Mehrnaz Gharaee-Kermani; Margaret R Gyetko; Biao Hu; Sem H Phan
Journal:  Pharm Res       Date:  2007-03-01       Impact factor: 4.580

6.  Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study.

Authors:  Sang Hoon Lee; Song Yee Kim; Dong Soon Kim; Young Whan Kim; Man Pyo Chung; Soo Taek Uh; Choon Sik Park; Sung Hwan Jeong; Yong Bum Park; Hong Lyeol Lee; Jong Wook Shin; Eun Joo Lee; Jin Hwa Lee; Yangin Jegal; Hyun Kyung Lee; Yong Hyun Kim; Jin Woo Song; Sung Woo Park; Moo Suk Park
Journal:  Respir Res       Date:  2016-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.